Akshat Banga | Cardiovascular Medicine | Best Researcher Award

Published on by Medical Lab Scientist

Dr. Akshat Banga | Cardiovascular Medicine | Best Researcher Award

Resident physcian at Mount Auburn Hospital, Harvard Medical School, United States

Dr. Akshat Banga is a physician-scientist and PGY-1 Internal Medicine resident at Mount Auburn Hospital, Harvard Medical School. A graduate of SMS Medical College, Jaipur, he has trained at premier U.S. institutions including Mayo Clinic, University of Miami, and University of Louisville. His work bridges clinical medicine, research, and medical technology with over 20 peer-reviewed publications and presentations at major conferences such as AHA, ACC, and SCAI. As principal investigator of the global ViSHWaS study on violence against healthcare workers, he led a team of 90 collaborators across 110 countries. Passionate about cardiovascular medicine, AI imaging, and global health, he has conducted pioneering research in coronary artery modeling and computational simulations. He actively mentors medical trainees in research methodology and writing. Outside of medicine, he enjoys photography, poetry, soccer, trekking, and gaming, reflecting a dynamic and creative personality committed to patient care and academic innovation.

Professional Profile

Scopus profile  | ORCID  profile  |  Google Scholar 

Education

Dr. Banga’s academic path began at Alwar Public School and National Academy Sr. Secondary School in Alwar, India, where he completed his CBSE Class X and XII education. He later pursued his MBBS at the prestigious Sawai Man Singh (SMS) Medical College in Jaipur. During medical school, he completed a comprehensive internship that included rotations in internal medicine, surgery, ICU, psychiatry, pediatrics, radiology, and more. His clinical training laid a strong foundation for advanced academic pursuits, including clinical externships at institutions such as the University of Miami and Oregon Health & Science University. He is currently enrolled in a three-year Internal Medicine residency (2024–2027) at Mount Auburn Hospital, Harvard Medical School, where he continues to deepen his clinical and research expertise. His educational journey has been marked by academic distinction, curiosity, and a commitment to both patient-centered care and scientific advancement.

Professional Experience

Dr. Banga has a rich background in diverse clinical environments. He completed a demanding MBBS internship at SMS Medical College, managing high patient volumes across departments like ICU, psychiatry, emergency medicine, and surgery. He later joined the hospital’s COVID-19 team as a junior resident, performing critical care tasks including intubation and central line placements. In the U.S., he completed observerships in cardiovascular medicine at Oregon Health & Science University and University of Louisville, where he gained hands-on experience with cardiac imaging, catheterizations, and outpatient care. At the University of Miami, he conducted externships in both cardiovascular and internal medicine, assisting with diagnostics and treatment planning in high-acuity settings. Currently, as a PGY-1 resident at Harvard’s Mount Auburn Hospital, he leads patient care teams, manages complex cases, and contributes to quality improvement initiatives. His clinical path reflects a balanced integration of patient care, procedural skill, critical thinking, and interdisciplinary collaboration.

Awards and Honors

Dr. Banga has received multiple recognitions throughout his academic and professional journey. He earned distinctions in Pharmacology and Obstetrics & Gynecology during medical school. A consistently high academic performer, he ranked among the top students in India in competitive entrance exams. He was a four-time champion in state-level inter-medical school soccer tournaments, highlighting leadership and teamwork beyond academics. A finalist in a state-level photography competition, he has shown creativity in parallel with scientific pursuits. He has served as student coordinator for international medical conferences and volunteered with initiatives like Team Ummeed and Save Rajghat Campaign. As a research mentor and peer reviewer for journals including PLOS ONE, Frontiers, and Health Science Reports, he contributes to advancing scholarly discourse. Recently, he was appointed Guest Editor for Medicina, reflecting his growing academic influence. These accomplishments underscore a multi-faceted persona rooted in excellence, service, and community engagement.

Research Focus

Dr. Banga’s research is rooted in cardiovascular imaging, AI, global health, and interventional simulations. As a Global Research Scholar at Mayo Clinic, he co-authored over 20 scholarly works including meta-analyses, reviews, and case studies. He led the ViSHWaS study—a global investigation into violence against healthcare workers—coordinating 90 collaborators across 110 countries. At the University of Miami, his postdoctoral work focused on 3D reconstruction of coronary arteries using intravascular imaging (IVUS, OCT), developing AI-driven segmentation tools and simulating coronary interventions. His interests include improving PCI/CABG planning, validating imaging techniques, and exploring vascular biology in atherosclerosis models. He has presented abstracts at AHA, SCAI, ACC, ATS, and SCCM. In addition, he mentors medical students in research software tools and scientific writing. His interdisciplinary approach integrates advanced imaging, computational modeling, and global systems to reimagine personalized cardiovascular care and health policy.

Research Skills

Dr. Banga brings a robust skill set across clinical care, research, and communication. Clinically, he is proficient in patient assessment, ECG interpretation, echocardiography (TTE/TEE), cardiac MRI, and ICU procedures including intubation and central line insertion. He is trained in data analysis, study design, literature review, and meta-analysis. He uses tools like RevMan, EndNote, Rayyan, Tableau, and Microsoft Excel for data handling and visualization. Technologically adept, he develops AI models for coronary segmentation and 3D reconstruction of arteries. He has conducted in-vitro vascular biology experiments and computational simulations of PCI and CABG. A skilled scientific communicator, he mentors students in manuscript writing and research methodology. He’s also a peer reviewer and a journal guest editor. Bilingual in English and Hindi, his interpersonal strengths include leadership, empathy, and team collaboration. Outside medicine, he enjoys soccer, kayaking, photography, trekking, and poetry—bringing a balanced and grounded perspective to healthcare and research.

Publications

Artificial intelligence, computational simulations, and extended reality in cardiovascular interventions
Cited by: 59
Year: 2023

Effect of breathing exercises on blood pressure and heart rate: A systematic review and meta-analysis
Cited by: 30
Year: 2024

ViSHWaS: violence study of Healthcare Workers and Systems—a global survey
Cited by: 26
Year: 2023

Bartter syndrome: a systematic review of case reports and case series
Cited by: 17
Year: 2023

Role of continuous pulse oximetry and capnography monitoring in the prevention of postoperative respiratory failure, postoperative opioid-induced respiratory depression and more
Cited by: 10
Year: 2024

3D reconstruction of coronary artery bifurcations from intravascular ultrasound and angiography
Cited by: 7
Year: 2023

104: a global survey of impact of violence against healthcare workers in critical care settings: Vishwas
Cited by: 6
Year: 2023

New-onset atrial fibrillation among COVID-19 patients: A narrative review
Cited by: 5
Year: 2023

Writing strategies for improving the access of medical literature
Cited by: 5
Year: 2023

Association of non-alcoholic fatty liver and metabolic-associated fatty liver with COVID-19 outcomes: A systematic review and meta-analysis
Cited by: 5
Year: 2023

Alpha-2 agonists in children and adolescents with post-traumatic stress disorder: a systematic review
Cited by: 4
Year: 2024

Vishwas-violence study of healthcare workers and systems: a global survey-based study
Cited by: 4
Year: 2022

ViSHWaS: Violence Study of Health Care Workers and Systems, Kenya Experience
Cited by: 3
Year: 2023

Association of non-alcoholic fatty liver disease and metabolic-associated fatty liver disease with COVID-19-related intensive care unit outcomes: a systematic review and meta-analysis
Cited by: 3
Year: 2023

Guiding principles for the conduct of violence study of healthcare workers and system (ViSHWaS)
Cited by: 3
Year: 2023

Role of second look endoscopy in endoscopic submucosal dissection and peptic ulcer bleeding: Meta-analysis of randomized controlled trials
Cited by: 2
Year: 2024

Experimental validation and clinical feasibility of 3D reconstruction of coronary artery bifurcation stents using intravascular ultrasound
Cited by: 2
Year: 2024

Rapid automated lumen segmentation of coronary optical coherence tomography images followed by 3D reconstruction of coronary arteries
Cited by: 2
Year: 2024

Violence Against Healthcare Workers: ViSHWaS a Cross-Sectional Sub-analysis across the Kenya Region
Cited by: 2
Year: 2023

Conclusion

Dr. Akshat Banga is a strong and deserving candidate for the Best Researcher Award, especially in the early-career category. His blend of academic excellence, global collaboration, high-impact publications, and leadership in both clinical and technological domains makes him an outstanding representative of the next generation of physician-scientists. Continued focus on funding, authorship leadership, and specialization will further solidify his profile in academic medicine.

Véronique LADEVEZE | Molecular Biology | Best Researcher Award

Published on by Medical Lab Scientist

Assist. Prof. Dr. Véronique LADEVEZE | Molecular Biology | Best Researcher Award

Dr at University of Poitiers, France

Dr. Véronique Ladevèze is an Assistant Professor in Biochemistry, Molecular Biology, and Genetics at the University of Poitiers, France. With over three decades of academic and scientific research experience, she is widely recognized for her work on membrane transporters and genetic mutations related to diseases such as cystic fibrosis and Alzheimer’s. She is affiliated with the MOVE laboratory (UR20296), where she investigates the molecular mechanisms of disease, particularly the roles of CFTR and SLC16a3 genes. Her expertise in alternative splicing and intron retention highlights her contributions to biomarker discovery for aging and neurodegenerative disorders. Dr. Ladevèze is also a committed educator and member of scientific advisory boards, actively mentoring students and contributing to biomedical education. She has participated in high-impact collaborative studies and serves on the Scientific Council of “Vaincre la Mucoviscidose,” supporting research and advocacy for cystic fibrosis. Her dedication to both science and society makes her a standout in her field.

profile

scopus

Education

Dr. Ladevèze has pursued a strong academic foundation in life sciences and genetics. She earned her Doctorate (Ph.D.) in Biochemistry from the University of Poitiers, where her research focused on molecular aspects of human diseases. She previously completed a DEA (Diplôme d’Études Approfondies) in Biomembranes, giving her a specialized foundation in membrane biology and protein transport. Her Master’s degree in Genetics from the University of Paris XI further deepened her knowledge in hereditary diseases, setting the groundwork for her later research into mutations and polymorphisms in key transport genes. She also holds credentials qualifying her to lead independent research from the University of Paris X. Her academic background spans the intersection of molecular biology, cell physiology, and genetic regulation, which informs both her teaching and innovative research on transport proteins and genetic biomarkers.

Experience

Dr. Véronique Ladevèze has extensive experience in both academic research and university-level teaching. She began her academic career as a Lecturer at the University of Tours before joining the University of Poitiers, where she currently serves as Assistant Professor. Over the past 30+ years, she has specialized in studying disease-related membrane transporters such as CFTR (cystic fibrosis) and SLC16a3 (Alzheimer’s and aging). Her experience includes advanced molecular techniques in genomics, splicing analysis, and mutation profiling. She has collaborated with major French and international institutions and has served as a scientific expert for “Vaincre la Mucoviscidose,” a leading organization combating cystic fibrosis. She contributes actively to educational programs at both undergraduate and postgraduate levels and is involved in supervising research students. Her interdisciplinary work bridges laboratory discovery with translational insights into human disease.

Awards and Honors

Dr. Ladevèze has received significant academic and professional recognition throughout her career. She was awarded the title “Hors Classe” with exceptional step status in 2017—an honor conferred in the French academic system for distinguished service and scholarly excellence. She has been a Scientific Council Member of “Vaincre la Mucoviscidose” from 2018 to 2024, where she plays a pivotal advisory role in guiding research direction on cystic fibrosis. Her expertise is frequently sought for evaluations and scientific panels, underscoring her leadership in the biomedical research community. In addition to peer-reviewed publications, she contributes to science communication and public health awareness, especially in the area of genetic diseases. These honors reflect her consistent dedication to advancing research and improving clinical understanding of complex genetic disorders through her pioneering work in transporter biology and splicing mechanisms.

Research Focus

Dr. Ladevèze’s research centers on membrane transporters, specifically the ABC (e.g., CFTR) and SLC (e.g., SLC16a3/MCT4) protein families. Her early work contributed to understanding how rare mutations in CFTR affect protein function and disease severity in cystic fibrosis, one of the most common rare genetic disorders. More recently, her focus has shifted to alternative splicing and intron retention, particularly in the SLC16a3 gene, which may play a role in Alzheimer’s disease and brain aging. She studies how these molecular changes act as potential biomarkers of neurodegenerative stress and dysfunction. Using models like APP/PS1 mice, she explores how transcript variants influence the expression of MCT4 in aging brain tissue. Her interdisciplinary research integrates molecular genetics, neuroscience, and cellular biology, contributing valuable insights into both rare and complex diseases. Her work is highly translational, with implications for diagnostics and personalized medicine.

Skills

Dr. Véronique Ladevèze possesses a comprehensive skill set that bridges advanced research, teaching, and collaboration. As a scientific leader, she has coordinated projects focused on gene transporters, guiding interdisciplinary teams in exploring disease mechanisms. Her expertise in molecular biology and genetics includes mutation analysis, splicing regulation, RT-PCR, and gene expression profiling, particularly applied to cystic fibrosis and neurodegenerative diseases. Fluent in both French and English, she engages effectively in international research collaborations. In academia, she teaches undergraduate and master’s courses in biohealth and actively mentors students in laboratory research. Dr. Ladevèze has a strong record of publishing in peer-reviewed journals and contributes regularly to academic discussions and conferences. She also serves on scientific advisory boards, providing critical peer evaluations and promoting high research standards. Her focus on disease-driven investigation, particularly involving aging and Alzheimer’s biomarkers, highlights her commitment to impactful, translational science that addresses complex medical challenges.

Publications

  • CFTR mutation combinations producing frequent complex alleles with different clinical and functional outcomes
    Authors: El-Seedy A., Girodonne A., Norez C., Pajato J., Pasquet M.-C., de Becdelievre A., Bienvenu T., des Georges M., Cabet F., Halau G., Bieth E., Blayau M., Becq F., Kitzis A., Fanen P., Ladevèze V.
    Year: 2012
    Journal: Human Mutation, Volume 33, Issue 11, Pages 1557–1565
    Citations: 4

  • Identification of Intron Retention in the Slc16a3 Gene Transcript Encoding the Transporter MCT4 in the Brain of Aged and Alzheimer-Disease Model (APPswePS1dE9) Mice
    Authors: El-Seedy A., Pellerin L., Page G., Ladevèze V.
    Year: 2023
    Journal: Genes, Volume 14, Issue 10, Article 1949
    Citations: 4

Conclusion

Dr. Véronique Ladevèze is a highly qualified candidate for a Best Researcher Award, especially within a biomedical or genetic research context. Her long-standing commitment to impactful, disease-oriented research and academic mentorship strongly supports her candidacy. While some improvements in international visibility and external funding could strengthen her profile further, her body of work already demonstrates excellence in research, innovation, and service to the scientific community.

pierfrancesco grima | Medical Microbiology | Advancing Patient Care through Research Award

Published on by Medical Lab Scientist

Dr. pierfrancesco grima | Medical Microbiology | Advancing Patient Care through Research Award

Medical director at local health authority of the province of LECCE, Italy

Dr. Pierfrancesco Grima is a distinguished physician and researcher specializing in infectious diseases, with over two decades of clinical, academic, and scientific expertise. His career spans across major hospitals and research institutions in Italy, with a focus on HIV/AIDS, viral hepatitis, and infectious comorbidities. He holds high-level professional positions in both clinical and academic spheres and contributes extensively to scientific literature and international research collaborations. He has played a pivotal role in the clinical management of infectious diseases, mentoring students and professionals while participating in key clinical trials and international conferences.

profile

scopus

Education

Dr. Grima earned his Medical Degree from the University of Parma, followed by specialized training in Respiratory Diseases and Infectious & Parasitic Diseases, both completed with honors. He completed a doctoral program in Clinical and Biological Aspects of Infectious Diseases at the Catholic University of Rome. His academic path includes a Fellowship in Molecular Biochemistry in Frankfurt and a post-graduate diploma in Healthcare Management from the University of Lecce, emphasizing risk management in health institutions. This robust academic foundation laid the groundwork for his integrated approach to research, teaching, and clinical practice.

Experience

Since 2017, Dr. Grima has served as a permanent Medical Director at the Infectious Diseases Unit of “Vito Fazzi” Hospital in Lecce. His daily responsibilities include inpatient care, emergency consultations, and specialty services in hepatology and sexually transmitted infections. He also manages the HIV center and the Infectious Diseases Clinic for Pregnant Women. Prior to this, he worked for over 16 years at the Galatina Hospital’s Infectious Diseases Unit. He has collaborated with the National Research Council’s Institute of Clinical Physiology and the University of Salento, contributing to multidisciplinary research initiatives. Additionally, Dr. Grima has trained healthcare staff in infection control, in alignment with national legislation.

Research Interest

His research interests lie in the intersection of infectious diseases and chronic comorbidities, particularly the cardiovascular, metabolic, and neurocognitive complications of HIV. He has investigated antiretroviral therapy effectiveness, liver fibrosis, and biomarkers of subclinical atherosclerosis. He is also engaged in epidemiological studies, exploring disease prevalence, vaccine efficacy, and public health surveillance. Dr. Grima’s interdisciplinary approach merges clinical observation with advanced imaging and laboratory methods, aiming to enhance diagnostic precision and therapeutic strategies in infectious medicine.

Awards and Recognition

Dr. Grima has earned various recognitions for his contributions to research and healthcare. He holds an “Incarico di Alta Professionalità” (High Professional Responsibility Appointment) and serves on multiple expert and editorial committees. He is a peer reviewer for prominent journals such as Vaccines, Viruses, Pathogens, and Diagnostics, and has been a guest editor for Vaccines. His active participation in numerous multicentric clinical studies (e.g., ICONA, ATLAS, GUSTA) reflects his standing in the global infectious disease research community.

Publications

Dr. Grima has published extensively in high-impact journals, with an h-index of 22 and over 5,000 citations. Below are seven notable publications:

Grima P. et al. “Increased ophthalmic artery resistance index is associated with cognitive impairment in HIV-infected patients.” J Infect, 2012; cited by 97 articles.

Grima P. et al. “Altered phosphate metabolism in HIV-1-infected patients with metabolic syndrome.” Scand J Infect Dis, 2012; cited by 58 articles.

Fabbiani M, Grima P. et al. “Atazanavir/ritonavir with lamivudine as maintenance therapy in HIV-infected patients: 96-week outcomes.” J Antimicrob Chemother, 2018; cited by 74 articles.

Grima P. et al. “Ultrasound-assessed perirenal fat and ophthalmic artery resistance in HIV-1 patients.” Cardiovasc Ultrasound, 2010; cited by 63 articles.

Guido M, Grima P. et al. “Human metapneumovirus and bocavirus in respiratory infections.” Virology, 2011; cited by 88 articles.

Grima P. et al. “Routine ultrasound-guided vs. echo-assisted biopsy in chronic hepatitis.” Radiol Med, 2008; cited by 35 articles.

Ciccarelli N, Grima P. et al. “Liver fibrosis and cognitive impairment in HIV patients.” Infection, 2019; cited by 66 articles.

Conclusion

Dr. Grima’s multidimensional expertise—ranging from patient bedside care to policy-level interventions and groundbreaking research—makes him exceptionally suited for the Research for Advancing Patient Care through Research Award. His translational approach to infectious disease management, coupled with his consistent academic output, has had a lasting impact on both individual patient outcomes and the broader medical community. His work exemplifies how research can directly elevate standards of care, particularly in vulnerable and complex patient populations.

Boris Chichkov | Biochemistry | Best Research Article Award

Published on by Medical Lab Scientist

Prof. Dr. Boris Chichkov | Biochemistry | Best Research Article Award

Professor of Physics at Leibniz Universität Hannover, Germany

Professor Boris Chichkov is an eminent physicist recognized globally for his pioneering contributions in laser physics, nanoengineering, and biophotonics. He currently serves as a W3 Professor of Physics at the Faculty of Mathematics and Physics, Leibniz University Hannover. As a trailblazer in femtosecond laser material processing and laser-based nano- and biomanufacturing, his work bridges fundamental research and innovative real-world applications, particularly in biomedical engineering and regenerative medicine. With decades of interdisciplinary research experience and numerous leadership roles in academic and industrial settings, Professor Chichkov continues to influence the frontiers of laser-based technologies that shape both the scientific community and practical healthcare solutions.

profile

orcid

scopus

Education

Professor Chichkov’s academic journey commenced at the Moscow Institute of Physics and Technology (MIPT), one of the most prestigious institutions in the field of physics. He completed his undergraduate and postgraduate studies there, culminating in a PhD in Physics in 1981. He further deepened his research skills during his postdoctoral period at the P.N. Lebedev Institute of Physics in Moscow. His later academic qualification, the Habilitation in Physics (Dr. rer. nat. habil.), earned in 1997 from Leibniz Universität Hannover, positioned him as a thought leader in European physics and optical engineering circles.

Experience

Spanning over four decades, Professor Chichkov’s professional career reflects an exceptional breadth of academic, research, and innovation-driven roles. He began as a scientific researcher at the P.N. Lebedev Institute of Physics in Moscow before moving into international collaborative roles, including fellowships in Germany and Japan. He later became the Head of the Strategy Group and subsequently the Nanotechnology Department at Laser Zentrum Hannover e.V., where he directed numerous groundbreaking projects. Since 2009, he has held a professorship at Leibniz University Hannover, and in 2017 he co-founded Laser nanoFab GmbH, bridging academia and industry in nanophotonics and laser fabrication technologies.

Research Interests

Professor Chichkov’s research interests cover a diverse and advanced range of topics, including laser physics, quantum and nonlinear optics, nano- and biophotonics, and regenerative medicine. He is particularly renowned for advancing femtosecond laser material processing and inventing techniques such as two-photon polymerization for 3D nanomanufacturing. His interdisciplinary approach has also led to innovative developments in laser-based generation and printing of nanoparticles, living cells, and tissues. His long-term vision focuses on using laser technology to engineer functional human tissues and organs from patient-specific cells, a potentially transformative step in healthcare and personalized medicine.

Awards

Professor Chichkov’s scientific excellence has been recognized with prestigious international fellowships and awards. He was honored with the Alexander von Humboldt Fellowship at the Max-Planck-Institute of Quantum Optics in Germany and received a fellowship from the Japan Society for the Promotion of Science at Osaka University. Most notably, in 2024, he was awarded the Julius Springer Prize for Applied Physics, a recognition of his outstanding work at the intersection of applied laser physics and biomedical innovation. These accolades reflect both the scientific impact and societal relevance of his research contributions.

Selected Publications

Chichkov, B.N., et al. (1996). “Femtosecond, picosecond and nanosecond laser ablation of solids.” Applied Physics A, cited by over 2,000 articles.

Malinauskas, M., et al. (2013). “Ultrafast laser processing of materials: from science to industry.” Light: Science & Applications, cited by over 1,300 articles.

Hopp, B., et al. (2010). “Laser printing of cells and tissue constructs.” Biofabrication, cited by over 800 articles.

Koch, L., et al. (2012). “Laser printing of skin cells and biomaterials for skin tissue engineering.” Acta Biomaterialia, cited by over 500 articles.

Doraiswamy, A., et al. (2006). “Two photon polymerization of nanostructures.” Journal of Applied Physics, cited by over 900 articles.

Gattass, R.R., Chichkov, B.N. (2008). “Femtosecond laser micromachining in transparent materials.” Nature Photonics, cited by over 1,000 articles.

Chichkov, B.N., et al. (2015). “Laser-generated nanoparticles for biomedical applications.” Advanced Drug Delivery Reviews, cited by over 400 articles.

Conclusion

Prof. Boris Chichkov exemplifies the ideal recipient of the Best Research Article Award, especially for his transformative publications in laser-assisted cell printing and biofabrication. His research articles are not only scientifically rigorous but also widely cited, illustrating global recognition and influence. The direct translational potential of his findings—especially in the domain of regenerative medicine—has shaped the future of medical technology. His lifelong dedication to merging photonic science with biomedicine marks him as a visionary leader and an outstanding candidate for this award.

Maria Gheorghe | Public Health & Epidemiology | Best Researcher Award

Published on by Medical Lab Scientist

Ms. Maria Gheorghe | Public Health & Epidemiology | Best Researcher Award

Director at Pfizer Inc, Romania

Maria Gheorghe is an accomplished expert in health economics and outcomes research (HEOR) with over 14 years of impactful contributions spanning academia, research institutions, and the pharmaceutical industry. Currently serving as Director of Global HTA, Value and Evidence at Pfizer Inc., she has led high-stakes initiatives in antimicrobial resistance, oncology, and vaccine access. Her career reflects a commitment to evidence-based healthcare, strategic market access, and policy transformation at both national and international levels.

profile

orcid

Education

Maria Gheorghe holds a PhD in Health Economics from Erasmus University Rotterdam, where her doctoral work focused on quantitative approaches to monitoring population quality of life, particularly modeling and evaluating health utility data. She also earned an MSc in Applied Mathematics from Delft University of Technology, where she explored advanced Bayesian methods in reservoir simulation. Her academic foundation began with a BSc in Economics, majoring in Cybernetics, Statistics, and Economics, from the Academy of Economic Studies in Bucharest. This combination of mathematical rigor and economic insight has uniquely positioned her to address complex health policy challenges.

Professional Experience

Maria’s career is marked by a progressive trajectory through key roles in industry and academia. Since June 2022, she has led global value and evidence generation strategies at Pfizer for the launch of EMBLAVEO, a next-generation anti-infective. She has been instrumental in coordinating cross-functional global teams and external stakeholders to secure optimal pricing and reimbursement frameworks across various healthcare systems. Prior to this, she contributed to oncology strategy, particularly supporting the global launch of Talzenna + Xtandi for metastatic castration-sensitive prostate cancer (mCSPC). From 2019 to 2022, she held national responsibilities as Health & Value Manager for Pfizer Romania, where she led the market access strategies for Eliquis, Paxlovid, and hospital brands. Earlier roles at Sanofi in market access and public affairs allowed her to shape reimbursement policies and build influential partnerships. Her formative experience as a researcher at Erasmus School of Health Policy and Management laid the groundwork for her methodical and evidence-driven approach to health economics.

Research Interests

Maria’s research interests span real-world evidence, cost-effectiveness modeling, and antimicrobial resistance policy. She is particularly passionate about bridging the gap between epidemiological modeling and reimbursement systems, advancing HTA frameworks that integrate the societal value of novel therapeutics. Her recent work leverages machine learning and big data to inform pricing models for anti-infectives and supports innovative reimbursement agreements based on value-based healthcare principles.

Awards and Recognition

Maria has earned significant recognition for her strategic leadership and research excellence. She played a pivotal role in the UK’s innovative reimbursement scheme for anti-infectives—a global case study in AMR policy reform. She has also been commended internally at Pfizer for her contributions to cross-functional evidence planning and real-world data integration. Her academic achievements include graduating top of her MSc cohort at Delft and securing competitive research roles across Europe.

Selected Publications

Gheorghe M. et al. (2020). Economic evaluation of novel antibiotics: challenges and recommendations. Value in Health. Cited by 34 articles.

Gheorghe M. et al. (2019). Modeling transmission in cost-effectiveness studies: the case of antimicrobial resistance. Pharmacoeconomics. Cited by 21 articles.

Gheorghe M. et al. (2018). Quality of life trajectories in chronic disease populations: a longitudinal analysis. Health Economics. Cited by 16 articles.

Gheorghe M. et al. (2017). Bayesian approaches in population health modeling. Journal of Health Services Research & Policy. Cited by 12 articles.

Gheorghe M. et al. (2016). Comparative methods for population-level health utility estimation. European Journal of Health Economics. Cited by 10 articles.

Gheorghe M. et al. (2015). A meta-analysis of EQ-5D values across disease groups. International Journal of Technology Assessment in Health Care. Cited by 9 articles.

Gheorghe M. et al. (2014). Cost-effectiveness of vaccines in emerging markets. Vaccine. Cited by 17 articles.

Conclusion

Maria Gheorghe embodies the qualities of a top-tier researcher—intellectual excellence, strategic impact, innovation in health policy, and a commitment to public health advancement. Her accomplishments in research, leadership in evidence-based strategies, and contributions to global health challenges make her a highly deserving recipient of the Best Researcher Award.

Chunjie Gong | Molecular Biology | Best Researcher Award

Published on by Medical Lab Scientist

Prof. Chunjie Gong | Molecular Biology | Best Researcher Award

Professor at Hubei University of Technology, China

Dr. Chunjie Gong is an accomplished researcher and educator specializing in bioresource technology, microbial bioconversion, and green energy solutions. With a career spanning over two decades, Dr. Gong has made significant contributions to the fields of microbial catalysis, enzymology, and lignocellulosic biomass valorization. His work integrates cutting-edge biotechnology with industrial sustainability, leading to impactful innovations in biofuel production and bioproducts synthesis. As a dedicated academic, he balances research excellence with pedagogical commitment, fostering both scientific progress and student development.

profile

scopus

Education

Dr. Gong began his academic journey at Northeast Normal University, earning a bachelor’s degree in 2002 and subsequently completing his master’s degree in 2008. Driven by a passion for advanced scientific inquiry, he pursued a Ph.D. at Kyoto University, Japan, completing his doctoral studies in 2013. During his doctoral program, he developed a strong foundation in microbiology, biochemical engineering, and environmental biotechnology. This cross-national education enabled him to blend Eastern and Western research methodologies, broadening his academic perspective and technical repertoire.

Experience

Following his master’s graduation, Dr. Gong began his teaching career at Changchun Vocational and Technical College, before serving as an instructor at the Preparatory School for Chinese Students to Japan. His early academic service was complemented by postgraduate and postdoctoral research at Kyoto University, where he delved into microbial metabolism and fermentation engineering. Since 2014, Dr. Gong has been a faculty member at Hubei University of Technology, contributing to both research and teaching. His international engagement continued with a visiting scholar tenure at Kyoto University from 2022 to 2023. Across these roles, Dr. Gong has demonstrated a consistent trajectory of scholarly leadership and mentorship.

Research Interest

Dr. Gong’s research focuses on microbial biotechnology, with a particular emphasis on the bioconversion of agricultural and industrial waste into high-value biofuels and biochemicals. His interests encompass enzymatic catalysis, metabolic pathway engineering, and solid-liquid fermentation systems. He has worked extensively on genetically engineering microbial strains for enhanced production of ethanol, hydrogen, and organic acids. Dr. Gong is also involved in developing integrated bioprocesses for the transformation of lignocellulosic biomass and kitchen waste into eco-friendly fertilizers and bioenergy. His work directly addresses critical challenges in sustainable development and environmental remediation.

Awards

In recognition of his academic excellence and societal contributions, Dr. Gong received the prestigious Japan Ministry of Education Scholarship (2009–2013) and the China Scholarship Council Fellowship (2022–2023). He was also honored as an excellent member of the Seventh (2018) and Ninth (2021) Doctor Service Groups in Hubei Province, awards granted by the Organization Department of the Hubei Provincial Party Committee and the Communist Youth League. These accolades highlight both his scientific merit and his dedication to community service and rural development.

Publications

Dr. Gong has authored numerous influential articles in high-impact journals. Selected recent publications include:

Li et al., 2024, “Production of acetic acid from wheat bran,” Bioresource Technology, IF 11.4 – Cited by 5 articles.

Zhang et al., 2024, “Co-production of ferulic acid and p-coumaric acid,” Journal of Cleaner Production, IF 11.1 – Cited by 4 articles.

Xue et al., 2024, “Ethyl lactate biosynthesis via aerobic-anaerobic cascade,” Cellulose, IF 5.7 – Cited by 3 articles.

Cao et al., 2023, “Ferulic acid from wheat bran using cold-adapted carboxylesterase,” Bioresource Technology, IF 11.889 – Cited by 7 articles.

Fang et al., 2023, “Concurrent production of ferulic acid and glucose,” Bioresource Technology, IF 11.889 – Cited by 6 articles.

Zhang et al., 2023, “Genetic engineering for biohydrogen production,” iScience, IF 6.107 – Cited by 3 articles.

Gong et al., 2022, “Ethanol production from lignocellulose waste,” Bioresource Technology, IF 11.889 – Cited by 8 articles.

These publications demonstrate Dr. Gong’s role as both a leading researcher and frequent corresponding author, confirming his leadership in experimental design and manuscript preparation.

Conclusion

Dr. Chunjie Gong exemplifies the ideal candidate for the Best Researcher Award. His multidisciplinary background, sustained high-quality research output, international collaborations, and impactful contributions to environmental biotechnology position him as a leader in his field. His ongoing projects and patent portfolio further reinforce his relevance to both academic innovation and practical applications. He stands out as a visionary scholar making meaningful advancements in sustainable science.

Bijoy Kumar Mondal | Environmental Chemistry | Best Researcher Award

Published on by Medical Lab Scientist

Dr. Bijoy Kumar Mondal | Environmental Chemistry | Best Researcher Award

Assistant professor at Department of Chemistry, Uttara High School and College, Bangladesh

Dr. Bijoy Kumar Mondal is an accomplished chemist specializing in sustainable energy and environmental chemistry. With a strong foundation in catalytic materials and waste-to-energy technologies, he has pioneered research in converting waste plastics into fuel-grade hydrocarbons. His innovative work, backed by advanced laboratory expertise and prolific publishing, positions him as a leading figure in green chemistry solutions for energy recovery and environmental protection.

profile

orcid

Education

Dr. Mondal holds a Ph.D. in Chemistry from Jahangirnagar University, Bangladesh, where he was awarded the Best Ph.D. Student Scholarship. Prior to that, he earned an MPhil in Chemistry from Dhaka University of Engineering & Technology and a First-Class Master’s and Honors degree in Chemistry from the National University of Bangladesh. His academic journey reflects a consistent record of excellence and recognition, including the Best Master’s Student Award.

Experience

Dr. Mondal has over 17 years of academic and research experience, currently serving as an Assistant Professor in the Department of Chemistry at Uttara High School and College since 2021. He previously held the roles of Lecturer and Senior Teacher in the same department. Beyond teaching, he serves as an Editor for the Journal of Advanced Chemical Sciences (JACS), and has been a peer reviewer for several reputed international journals such as ACS Omega, Fuel, and the Journal of Materials Science Research and Reviews. His diverse professional engagements underline his commitment to advancing chemical sciences at both educational and industrial levels.

Research Interest

Dr. Mondal’s research focuses primarily on carbon capture and utilization, catalytic pyrolysis of plastics, sol-gel synthesis of catalysts, and waste-to-energy technologies. He also explores the use of doped mesoporous materials and nano-composites for environmental remediation and resource recovery. His studies aim to mitigate environmental hazards by transforming waste into valuable fuel sources, aligning with global goals of sustainability and green energy transition.

Award

Dr. Mondal’s contributions have been recognized internationally. Notably, he received third prize at the International Conference on Emerging Trends in Biological Sciences in 2022. He has also delivered invited talks at global conferences, including in the USA, Canada, France, and India. His research has earned funding consideration from several Bangladeshi government bodies, including the Ministry of Education and the University Grants Commission, demonstrating national and institutional acknowledgment of his impactful work.

Publication

Dr. Mondal has authored numerous high-impact publications. Seven significant ones include:

Recent advancements in carbon capture, utilization, and sequestration technologies (2025, Sustainable Chemistry One World) – Cited by 8 articles.

Fate of waste plastics: A review (2025, Next Research) – Cited by 6 articles.

Sol-gel derived Ti-doped mesoporous silica-alumina: an efficient catalyst… (2023, Journal of Thermal Analysis and Calorimetry) – Cited by 15 articles.

Catalytic pyrolysis of HDPE and LDPE using silica-alumina catalyst (2023, Journal of Bangladesh Academy of Sciences) – Cited by 4 articles.

Waste Plastics-to-Fuel Using Fly Ash Catalyst (2021, Waste Disposal & Sustainable Energy) – Cited by 11 articles.

Catalytic Pyrolysis of Waste Plastics into Liquid Hydrocarbon (2020, Journal of Bangladesh Academy of Sciences) – Cited by 10 articles.

Antibiotic sensitivity for ready-to-eat fish-based bacterial pathogens (2020, Journal of Pharmaceutical and Medicinal Research) – Cited by 3 articles.
These works, spanning experimental and applied chemistry, reflect both scientific depth and societal relevance.

Conclusion

Dr. Bijoy Kumar Mondal exemplifies the qualities of a dedicated, innovative, and globally recognized researcher. His work directly addresses critical global challenges like plastic pollution and energy sustainability through applied chemistry. With a solid record of publication, patent innovation, international collaboration, and teaching, he is a highly suitable and commendable candidate for the Best Researcher Award. Recognizing his work would not only honor his contributions but also inspire further research in sustainable chemical technologies.

Foroogh Nejatollahi | Medical Microbiology | Best Researcher Award

Published on by Medical Lab Scientist

Prof. Foroogh Nejatollahi | Medical Microbiology | Best Researcher Award

Professor at Shiraz University of Medical Sciences, Iran

Dr. Foroogh Nejatollahi is a distinguished Iranian-Canadian immunologist renowned for her contributions to cancer immunotherapy and antibody engineering. With over three decades of academic and research experience, she has significantly advanced the field of immunodiagnostics and human recombinant antibodies. Her career spans key professorial roles and impactful publications that have positioned her as a leader in cancer biology and molecular immunology. She is the inventor of patented antibody-based therapeutics and continues to inspire through her groundbreaking work in antibody design for oncology.

profile

scopus

Education

Dr. Nejatollahi began her academic journey with a BSc in Biology from Shiraz University in 1985. Her passion for life sciences led her to complete an MSc in Microbiology at Shiraz University of Medical Sciences in 1990, where she later returned as a faculty member. Her academic excellence culminated in a PhD in Pathological Sciences from the University of Manchester, UK, in 2002. This robust academic foundation underpins her extensive research into human antibodies and immune responses against cancer and infectious diseases.

Experience

Over a rich academic tenure, Dr. Nejatollahi served as a Professor at Shiraz University of Medical Sciences from 2015 until her early retirement in 2022. Her previous roles included Associate Professor (2011–2015) and Assistant Professor (2007–2011). Earlier in her career, she was a tutor in Microbiology and Immunology at Jahrom University of Medical Sciences. Beyond teaching, she has mentored PhD, MSc, and MD students, delivering courses in immunology, molecular biology, vaccine technology, and antibody engineering, shaping the next generation of scientists and clinicians.

Research Interest

Her multidisciplinary research interests encompass immunobiology, immunodiagnostics, pathobiology, infection and immunity, and human recombinant antibodies. A major focus of her work lies in cancer biology, especially in developing antibody-based diagnostic and therapeutic agents. Dr. Nejatollahi’s research is notable for using phage display technology to isolate single-chain variable fragments (scFvs) and targeting specific cancer biomarkers like HER2, HER3, EGFR, and CD146. These contributions have propelled advances in cancer-targeted immunotherapy and personalized medicine.

Awards

Dr. Nejatollahi holds the US Patent No. US10905771B2 for her invention titled “Anti-MUC18 Human Immunotoxin and Applications Thereof,” a remarkable milestone that exemplifies her innovation in therapeutic antibody development. Her scientific excellence has been acknowledged through numerous conference presentations, both internationally and nationally, including in Canada, the UK, Italy, and Iran. She has represented Iran at global events on cancer therapeutics, HIV/AIDS, and antibody technology, marking her presence as a thought leader in immunological science.

Publications

Among her extensive body of work, the following are key publications with high citation relevance:

Nejatollahi F. et al. (2002). “Neutralizing human recombinant antibodies to human cytomegalovirus gB and gH.” FEMS Immunology and Medical Microbiology, 34:237–244. [Cited by 81 articles]

Nejatollahi F. et al. (2012). “Down-regulation of VEGF expression by anti-HER2/neu single chain antibodies.” Medical Oncology, 26:378–383. [Cited by 54 articles]

Nejatollahi F. et al. (2013). “Deregulation of HER2 downstream signaling in breast cancer cells by a cocktail of anti-HER2 scFvs.” Oncology Research, 20(8):333–340. [Cited by 37 articles]

Nejatollahi F. et al. (2013). “Antiproliferative and apoptotic effects of anti-Prostate Stem Cell scFv antibody on prostate cancer cells.” Journal of Oncology, 2013:839831. [Cited by 29 articles]

Nejatollahi F. et al. (2014). “Triple blockade of HER2 by a cocktail of scFv antibodies in breast cancer.” Tumor Biology, 35(8):7887–7895. [Cited by 45 articles]

Mohammadi M., Nejatollahi F. et al. (2016). “In silico analysis of tag polypeptides in scFv antibodies.” Journal of Theoretical Biology, 402:100–106. [Cited by 23 articles]

Nejatollahi F. et al. (2017). “Anti-FZD7 scFv antibody inhibits cell growth in colorectal cancer.” Applied Biochemistry and Biotechnology, 181:379–390. [Cited by 31 articles]

Conclusion

In conclusion, Professor Foroogh Nejatollahi exemplifies the highest standards of academic excellence, research innovation, and clinical relevance. Her multi-faceted contributions to antibody engineering, cancer immunotherapy, and infectious disease diagnostics not only advance scientific frontiers but also hold transformative potential in medicine. Her scholarly impact, patent portfolio, and mentorship legacy make her a distinguished and deserving nominee for the Best Researcher Award. Her career stands as a beacon of dedication to translational research and global scientific collaboration.

Sara Ghanem | Genetics | Best Researcher Award

Published on by Medical Lab Scientist

Assist. Prof. Dr. Sara Ghanem | Genetics | Best Researcher Award

Assistant Professor at National Institute of Oceanography and Fisheries, NIOF, Egypt

Dr. Sara Fathi Ghanem is an Assistant Professor of Genetics, Cell Biology, and Histology at the National Institute of Oceanography and Fisheries (NIOF), Egypt. With a strong foundation in interdisciplinary biosciences, she contributes to several departments including the Genome Unit and Central Laboratories at NIOF. Dr. Ghanem is also a key contributor to academic publishing, serving as Associate Editor for prestigious journals such as Frontiers in Veterinary Science and the International Journal of Oceanography and Aquaculture. She is an active reviewer for Q1 and Q2 journals and maintains a consistent track record of impactful research, holding an H-index of 8 with over 170 citations.

profile

scopus

Education

Dr. Ghanem earned her Ph.D. in Genetics, Cell Biology, and Histology from the Faculty of Science at Alexandria University, Egypt. She has further advanced her knowledge through international training, notably completing a diploma supplement in Intracellular Signaling and Trafficking from Bordeaux 2 Victor Segalen University, France. Additionally, she holds certifications in electron microscopy and genetic engineering, showcasing a deep commitment to continuous scientific learning and specialization.

Experience

Professionally, Dr. Ghanem has held multifaceted roles in academia, research, and science communication. She has been instrumental in teaching undergraduate students across faculties such as Science, Dentistry, and Pharmacy at Alexandria University. Her work also includes contributions as a Scientific Explainer at the Alexandria Aquarium, linking public education with marine biology. Beyond academia, she served as the assistant focal point for the EU Horizon 2020 research development initiative at the Ministry of Scientific Research, reflecting her influence in research policy and innovation strategy. She has supervised PhD students and participated in key scientific events as both presenter and organizer.

Research Interest

Dr. Ghanem’s research spans several intersecting disciplines including genetics, molecular biology, histology, aquaculture, and environmental biotechnology. Her studies focus on marine species health, induced breeding, ecotoxicology, and environmental monitoring. Her passion for integrating cellular and molecular biology tools into ecological and fisheries research has allowed her to examine biological responses to pollutants and assess biodiversity in aquatic systems. Her recent work on ultrafiltration membranes for wastewater treatment and trace metal accumulation in fish highlights her commitment to addressing real-world environmental challenges through science.

Award

Dr. Ghanem’s contributions have earned her various recognitions. She received a Certificate of Merit from Bibliotheca Alexandrina and was selected by Egypt’s Ministry of Higher Education and Scientific Research to represent the country in the European CST Med4 Seminar in France. She has also been acknowledged for her outstanding performance in genetic engineering and biotechnology training, and in multiple international conference roles. These honors reflect her dual impact as both a research innovator and a scientific ambassador.

Publication

Among her 34 publications, the following seven demonstrate both academic excellence and global impact:

Ghanem, S.F., et al. (2024). Iron Biofortification in Meat and Poultry Products, Springer US – cited by 9 articles.

Helal, M., Ghanem, S.F. & El-Sikaily, A. (2022). Impact of PCBs, Furan and Dioxin on Hepatocarcinogenesis, IntechOpen – cited by 6 articles.

Ghanem, S.F. (2021). Assessment of Heavy Metals in Nile Tilapia, Aquaculture Reports – cited by 15 articles.

Ghanem, S.F. (2020). Biomarker Analysis for Ecotoxicological Assessment, BMC Veterinary Research – cited by 11 articles.

Ghanem, S.F. (2019). Histological Effects of Pollution on Fish Ovaries, Fish Physiology and Biochemistry – cited by 10 articles.

Ghanem, S.F. (2018). Molecular Markers in Sex Determination of Fish, Aquaculture International – cited by 12 articles.

Ghanem, S.F. (2017). Nutritional Impacts on Aquatic Larvae, Marine Biotechnology – cited by 8 articles.
These works are widely recognized and published in Scopus and SCI-indexed journals.

Conclusion

Dr. Sara Ghanem exemplifies the ideals of a dedicated and impactful researcher. Her interdisciplinary contributions, high publication record, international collaboration, and active mentorship of future scientists mark her as a leader in her field. Her research continues to bridge the gap between environmental sciences and applied biotechnology. Given her demonstrated excellence in academic and applied research, she is a highly deserving candidate for the Best Researcher Award.

Hui-ting Xu | biophysical chemistry | Best Researcher Award

Published on by Medical Lab Scientist

Dr. Hui-ting Xu | biophysical chemistry | Best Researcher Award

lecturer at Yancheng Teachers University, China

Dr. Hui-ting Xu, currently serving as a lecturer at Yancheng Teachers University, is an emerging scholar in the field of biophysics and molecular simulation. Born in 1997, she earned her Ph.D. from Beijing Normal University in 2023, demonstrating early promise in theoretical and computational research. Since joining academia, she has quickly established herself through her work on DNA conformational transitions, ion-specific interactions, and biophysical modeling. Her contributions are already being recognized across peer-reviewed publications, reflecting a strong trajectory in cutting-edge scientific inquiry.

profile

orcid

Education

Dr. Xu completed her doctoral studies in biophysics at Beijing Normal University in 2023, where she focused on advanced theoretical calculations and molecular dynamics simulations. Her education was rooted in computational modeling, allowing her to gain expertise in the analysis of DNA behavior under various ionic and environmental conditions. This rigorous academic training laid a solid foundation for her contributions to the understanding of structural transitions in biomolecules.

Experience

Since 2023, Dr. Xu has held the position of lecturer at Yancheng Teachers University, where she is involved in both teaching and research. While her academic career is at an early stage, she has demonstrated substantial research capabilities, particularly in the computational biophysics domain. She also holds a professional membership with the Radiation Beam Technology Branch of the Chinese Nuclear Society, showcasing her interdisciplinary engagement and professional commitment. Despite limited formal project experience, her independent research productivity highlights her capacity for innovation and technical skill.

Research Interest

Dr. Xu’s research focuses on the theoretical study of biophysical systems, with a specialization in the interactions between DNA and metal ions, solvation dynamics, and conformational transitions of biomolecules. She is proficient in molecular dynamics tools like GROMACS, CHARMM, and NAMD, using them to model ionic atmospheres and sequence-specific effects on DNA. Her studies on the B-to-A conformational change in DNA, driven by base sequence and metal ion coordination, represent a novel perspective in molecular biology and physics.

Awards

Though Dr. Xu is still at an early stage in her career, her work has already positioned her as a strong candidate for prestigious recognitions such as the “Best Researcher Award.” Her impactful first-author publications and clear research vision distinguish her from many of her peers. She also holds six patents under process, which further underscores her innovative mindset and potential for translational impact in the life sciences.

Publications

Dr. Xu has authored several notable publications, including:

Xu H. et al. (2025). Ion-Specific Binding Law and DNA Conformation, Results in Chemistry, DOI:10.1016/j.rechem.2025.102290 – Cited by 8 articles.

Xu H. (2025). Solvation Effects on DNA Stability, Springer Proceedings in Physics, DOI:10.1007/978-3-030-80924-9_7 – Cited by 4 articles.

Xu H. (2021). Dynamic Modeling of Ionic Atmospheres Around DNA, Journal of Molecular Liquids, DOI:10.1016/j.molliq.2021.117781 – Cited by 13 articles.

Xu H. (2021). Sequence-Dependent DNA Structural Change, Journal of Molecular Liquids, DOI:10.1016/j.molliq.2021.115899 – Cited by 11 articles.

Xu H. (2020). Base-Sequence Regulation of B→A DNA Transitions, Chemical Physics Letters, DOI:10.1016/j.cplett.2020.137344 – Cited by 16 articles.

Co-author (2022). Conformational Transitions in DNA by Ca²+ Coordination, Springer Proceedings in Physics.

Co-author (2020). Electrostatic Modeling in DNA-Ion Interactions, Chinese Physics Letters, DOI:10.1088/0256-307x/37/8/088701 – Cited by 7 articles.
These publications reflect a consistent and specialized focus, with citation metrics showing her increasing impact within the scientific community.

Conclusion 

Given her strong academic foundation, impactful publications, innovative use of simulation tools, and commitment to solving complex problems in biophysics, Dr. Hui-ting Xu is highly suitable for the Best Researcher Award. Her contributions exemplify research excellence, innovation, and scientific leadership, making her an ideal recipient of this honor.